Alveolitis care

Alveolitis, also referred to as pulmonary alveolar inflammation, represents a group of conditions in which the alveoli—the tiny air sacs in the lungs—become inflamed due to infection, autoimmune disorders, environmental exposures, or drug reactions. This inflammation can impair oxygen exchange, leading to breathlessness, persistent cough, fatigue, and in severe cases, hypoxemia. Accurate evaluation in alveolitis care involves detailed patient history, imaging studies such as high-resolution CT scans, pulmonary function testing, and sometimes bronchoalveolar lavage or lung biopsy to determine the underlying cause. Recognizing early signs is essential, as untreated alveolitis may progress to chronic interstitial changes and permanent lung damage.

Management of alveolitis emphasizes reducing inflammation, preventing progression, and supporting lung function. Pharmacologic therapy often includes corticosteroids and, where appropriate, immunosuppressive agents to control autoimmune-driven inflammation. Supportive measures such as supplemental oxygen, pulmonary rehabilitation, and infection prevention are critical in maintaining respiratory health. Patients are advised to avoid environmental triggers such as dust, fumes, or occupational exposures that could worsen alveolar injury. Long-term monitoring through imaging and lung function tests allows clinicians to adjust treatment as needed and detect early signs of relapse or fibrosis. Multidisciplinary coordination among pulmonologists, radiologists, and immunologists ensures a comprehensive approach, enhancing recovery and quality of life. With timely intervention and consistent follow-up, alveolitis care can effectively stabilize lung function and prevent long-term complications.